Decentralized Trials: Bringing Research to the People Over the COVID-19 period the medical industry was pushed to innovate and adopt modern technologies at a faster rate than ever. One way in which these innovations have manifested is through the rapid adoption of decentralized methods of conducting clinical research trials. These are trials which are conducted… Continue reading Decentralized Trials: Bringing Research to the People
The new Clinical Trial Regulation (CTR) is set to revolutionize clinical trial processes throughout Europe, affecting all European Union (EU) member states and organizations headquartered in other countries wishing to conduct clinical trials on Investigational Medicinal Products (IMPs) in the area. Clinical Trials Information System (CTIS), a centralized portal/application, will be used to standardize… Continue reading Clinical Trial Regulation (CTR) Will Transform Clinical Trial Processes
Capabilities of AI-Enabled Platforms Clinical trials may be revolutionized via the implementation of AI-enabled digital health technologies and patient support platforms such as Clinials, resulting in greater success in attracting, engaging, and retaining engaged participants throughout the study’s course. With artificial intelligence, clinical trial cycle duration can be shortened, while productivity and results in clinical… Continue reading Capabilities of AI-Enabled Platforms
Upcoming Layperson/Plain Language Summary (PLS) Regulations The much-anticipated 2014 European Union Clinical Trial Regulation 536 (EU CTR) requiring the sponsors and academic researchers conducting research trials to draft layperson/plain language summaries (PLS) is set to go into effect in 2023. The regulation will most likely flow to other countries and will be adopted by various… Continue reading Upcoming Layperson/Plain Language Summary (PLS) Regulations
Parallelization is a Good Approach in Clinical Trials The pandemic has forced the industry to develop and implement new methods of working, trial design, and data management. According to a recent Oracle and Informa survey, 63% of organizations have implemented some kind of protocol reform as they transition to a more decentralized trial model. Hence,… Continue reading Parallelization is a Good Approach in Clinical Trials
Managing Research and Clinical Trials Through COVID-19 Disruptions Living through the COVID-19 pandemic has taught us all — especially in the medical industry — many things about resilience, preparedness, and deliberation. The way the coronavirus moves and grows has proven to be erratic and unpredictable, and the public, private, and governmental sectors have all had… Continue reading Managing Research and Clinical Trials Through COVID-19 Disruptions
5 Lessons the Clinical Trial Industry Learned from COVID-19 Like the rest of the world, the coronavirus pandemic completely disrupted the medical industry. From offshoring trials to safer spaces, to nuanced discussions around ethics and timelines, we’ve seen huge changes specifically in the clinical testing process. Although the virus has devastated many industries, it has… Continue reading 5 Lessons the Clinical Trial Industry Learned from Covid-19
Why Aren’t Enough Women Represented in Clinical Trials? The lack of women participating in clinical trials is becoming an increasing concern as discussed recently in this interview with Dr Cheryl Carcel, Neurologist of the The George Institute for Global Health Professor Bruce Campbell, Neurologist, The Stroke Foundation. Most recently in a trial testing stroke medication,… Continue reading Why Aren’t Enough Women Represented in Clinical Trials?
What Trial can I Go on? Patients with a chronic illness are looking for answers and the best treatment when they visit their doctor or specialist. “What clinical Trial can I go on? is not usually asked by patients, however with new emerging treatments is it something that could be or should be asked by… Continue reading What Trial can I Go on?
US:
867 Boylston Street
5th Floor
Boston, MA 02116
